Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Interest & Investment Income (2024 - 2026)

Carlsmed filings provide 2 years of Interest & Investment Income readings, the most recent being $1.0 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 150.73% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 million, a N/A change, with the full-year FY2025 number at $2.7 million, up 102.86% from a year prior.
  • Interest & Investment Income hit $1.0 million in Q4 2025 for Carlsmed, up from $954000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.0 million in Q4 2025 to a low of $336000.0 in Q2 2025.